Analyst Ratings for Jazz Pharmaceuticals (JAZZ)
JAZZ Rating Summary
JAZZ Price Target Summary
- Highest: $337.00 (UBS)
- Lowest: $227.00 (Raymond James)
- Average: $290.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$290.60 (+35.8%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 87%
Rating Score: 8.7 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/30/2026 | Citi | Geoff M | New Coverage | Buy (N/A) |
325.00 (N/A) |
232.35 (214.00) |
-7.9% | Details |
| 9/24/2026 | Goldman Sachs | Andrea Newkirk | New Coverage | Buy (N/A) |
337.00 (N/A) |
240.57 (214.00) |
-11.04% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
